Photobiomodulation as a potential therapeutic strategy in COVID-19 management
Journal of Emergency Medicine: Open Access · 2023
DOI: 10.33140/jemoa.01.01.07 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Emergency Medicine: Open Access, 2023.
Abstract (Originalsprache)
The current outbreak of coronavirus disease 2019 (COVID-19) constitutes a global emergency. While numerous medications are employed in the treatment of COVID-19 patients, they may elicit a range of adverse effects. Photobiomodulation therapy (PBMT) is advocated for its noninvasive, painless, and secure biostimulative properties. Notably, recent findings indicate that PBMT has demonstrated promising clinical outcomes in COVID-19 patients. Those who received PBMT exhibited swift recovery with no discernible side effects during the clinical study. PBMT exhibits significant potential for anti-inflammatory and immunomodulatory effects, and these mechanisms are elucidated in this study. The present work suggests that PBMT holds tremendous potential for application in at-home patient care. Furthermore, PBMT can serve as an alternative and complementary therapy within the realm of clinical research practices.
Zitieren
APA
(2023). Photobiomodulation as a potential therapeutic strategy in COVID-19 management. Journal of Emergency Medicine: Open Access. https://doi.org/10.33140/jemoa.01.01.07
Vancouver
Photobiomodulation as a potential therapeutic strategy in COVID-19 management. Journal of Emergency Medicine: Open Access. 2023. doi:10.33140/jemoa.01.01.07
BibTeX
@article{euvimed2023,
title = {Photobiomodulation as a potential therapeutic strategy in COVID-19 management},
journal = {Journal of Emergency Medicine: Open Access},
year = {2023},
doi = {10.33140/jemoa.01.01.07}
}
EUVIMED